- Home
- TARA vs SANG Comparison
TARA vs SANG Comparison
Compare TARA & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- SANG
- Stock Information
- Founded
- TARA N/A
- SANG 1984
- Country
- TARA United States
- SANG Canada
- Employees
- TARA N/A
- SANG N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- SANG Computer Software: Programming Data Processing
- Sector
- TARA Health Care
- SANG Technology
- Exchange
- TARA Nasdaq
- SANG Nasdaq
- Market Cap
- TARA 196.8M
- SANG 168.6M
- IPO Year
- TARA N/A
- SANG 2021
- Fundamental
- Price
- TARA $5.12
- SANG $4.91
- Analyst Decision
- TARA Strong Buy
- SANG
- Analyst Count
- TARA 6
- SANG 0
- Target Price
- TARA $19.80
- SANG N/A
- AVG Volume (30 Days)
- TARA 455.2K
- SANG 5.3K
- Earning Date
- TARA 11-03-2025
- SANG 11-10-2025
- Dividend Yield
- TARA N/A
- SANG N/A
- EPS Growth
- TARA N/A
- SANG N/A
- EPS
- TARA N/A
- SANG N/A
- Revenue
- TARA N/A
- SANG $236,692,000.00
- Revenue This Year
- TARA N/A
- SANG N/A
- Revenue Next Year
- TARA N/A
- SANG $5.48
- P/E Ratio
- TARA N/A
- SANG N/A
- Revenue Growth
- TARA N/A
- SANG N/A
- 52 Week Low
- TARA $2.21
- SANG $4.08
- 52 Week High
- TARA $10.48
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- TARA 56.48
- SANG 45.05
- Support Level
- TARA $4.96
- SANG $4.88
- Resistance Level
- TARA $5.39
- SANG $5.20
- Average True Range (ATR)
- TARA 0.30
- SANG 0.13
- MACD
- TARA -0.10
- SANG 0.02
- Stochastic Oscillator
- TARA 20.00
- SANG 38.33
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.